Pharma Compliance Monitor (PCM) is only publication that spotlights regulatory and compliance news and developments for the pharmaceutical and biotechnology communities.

PCM’s ongoing goal is to create a place where pharmaceutical and biotechnology professionals and executives can go to stay informed, interact and learn.

Read by senior compliance professionals and executives at many of the largest research-based pharmaceutical and biotechnology manufacturers, PCM speaks to the decision maker faced with making mission critical choices that anchor best-in-class corporate compliance and ethics programs.

On a daily basis Chief Compliance Officers, VPs and Compliance Directors, Chief Audit Executives, VPs and Directors of Audit, Chief Compliance Counsel, VPs and Directors, CFOs and CEOs read PCM for news and insight that enables them to work smarter and safer.  PCM is also read by top law and consulting firms to ensure they are up-to-date and offering the most intelligent counsel to their clients.